# Eledon Pharmaceuticals, Inc.: Form 8-K, filed May 7, 2024

- Company: [Eledon Pharmaceuticals, Inc.](/companies/eldn.md) (CIK 1404281)
- Form: 8-K
- Filed: 2024-05-07
- Accepted by EDGAR: May 7, 2024, 07:15 ET
- Period: 2024-05-06
- Accession: 0000950170-24-053934
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1404281/000095017024053934/eldn-20240506.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1404281/000095017024053934/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1404281/000095017024053934/eldn-20240506.htm

Filed May 7, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-053934. Last ingested by Listed: Oct 30, 2026, 11:26 ET. No prices; not investment advice.